King George's Medical University
Clinical trials sponsored by King George's Medical University, explained in plain language.
-
Can a simple protein infusion prevent deadly Re-Bleeding in cirrhosis patients?
Disease control Not yet recruitingThis phase 3 trial tests whether adding albumin to standard treatment reduces re-bleeding and death in adults with cirrhosis who have acute variceal bleeding. Sixty participants will be randomly assigned to receive either albumin for three days plus standard care, or standard car…
Phase: PHASE3 • Sponsor: King George's Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New acid blocker may beat standard drug for Post-Banding ulcers in cirrhosis
Prevention Not yet recruitingThis phase 3 trial tests whether vonoprazan, a newer acid-blocking drug, is better than rabeprazole at preventing ulcers and bleeding after endoscopic variceal band ligation (EVL) in people with cirrhosis. About 300 adults with esophageal varices will take one of the two drugs da…
Phase: PHASE3 • Sponsor: King George's Medical University • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC